Mushrooms, Tumors, and Immunity: An Update

Experimental Biology and Medicine

Volumn 229, Issue 5, 2004, Pages 393-406

  Borchers, Andrea T ^a   Keen, Carl L ^a   Gershwini, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Carcinogenesis; Dietary supplements; Heavy metal contamination; Immune modulation; Mushrooms

Indexed keywords

ARSENIC; BETA GLUCAN; CADMIUM; CESIUM 137; CORIOLUS VERSICOLOR EXTRACT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOPHOSPHAMIDE; ERGOSTEROL; FLAMMULINA VELUTIPES EXTRACT; GANODERMA LUCIDUM EXTRACT; GRIFOLA FRONDOSA EXTRACT; GRIFOLAN; HYPSIZYGUS MARMOREUS EXTRACT; LEAD; LENTINAN; MERCURY; METAL; MUSHROOM EXTRACT; NATURAL PRODUCT; OXAZOLONE; PHOLIOTA NAMEKO EXTRACT; PLANT EXTRACT; PLEUROTUS ERYNGII EXTRACT; POLYSACCHARIDE; PROTEUS LINTEUS EXTRACT; SCHIZOPHYLLAN; SPARASSIS CRISPA EXTRACT; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CARCINOGENESIS; CELL ACTIVATION; CLINICAL TRIAL; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; EPIDEMIOLOGICAL DATA; HEALTH PROMOTION; HUMAN; IMMUNITY; IMMUNOBIOLOGY; IN VITRO STUDY; LENTINUS EDODES; LEUKOPENIA; METAL BINDING; MONONUCLEAR CELL; MOUSE; MUSHROOM; NONHUMAN; PHENOTYPE; RADIOACTIVE CONTAMINATION; RECEPTOR BINDING; SHORT SURVEY; STATISTICAL SIGNIFICANCE;

ANIMALIA; BASIDIOMYCOTA; CORIOLUS VERSICOLOR; FLAMMULINA; FLAMMULINA VELUTIPES; GANODERMA; GANODERMA LUCIDUM; GRIFOLA; GRIFOLA FRONDOSA; HYPSIZYGUS; HYPSIZYGUS MARMOREUS; LENTINULA EDODES; LENTINUS; PHOLIOTA; PHOLIOTA NAMEKO; PLEUROTUS; PLEUROTUS ERYNGII; SPARASSIS; SPARASSIS CRISPA;

EID: 2142642293     PISSN: 15353702     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020422900507     Document Type: Short Survey

References (90)

1. Borchers AT, Stern JS, Hackman RM, Keen CL, Gershwin ME. Mushrooms, tumors and immunity. Proc Soc Exp Biol Med 221:281-293, 1999.
2. Kim HJ, Chang WK, Kim MK, Lee SS, Choi BY. Dietary factors and gastric cancer in Korea: a case-control study. Int J Cancer 97:531-535, 2002.
3. García MA, Alonso J, Fernández MI, Melgar MJ. Lead content in edible wild mushrooms in Northwest Spain as indicator of environmental contamination. Arch Environ Contam Toxicol 34:330-335, 1998.
4. Svoboda L, Kalac P. Contamination of two edible agaricus spp. mushrooms growing in a town with cadmium, lead, and mercury. Bull Environ Contam Toxicol 71:123-130, 2003.
5. Travnikova IG, Shutov VN, Bruk GY, Balonov MI, Skuterud L, Strand P, Pogorely JA, Burkova TF. Assessment of current exposure levels in different population groups of the Kola Peninsula. J Environ Radioact 60:235-248, 2002.
6. Lee IS, Nishikawa A. Polyozellus multiplex. a Korean wild mushroom. as a potent chemopreventive agent against stomach cancer. Life Sci 73:3225-3234, 2003.
7. Fujimiya Y, Suzuki Y, Oshiman K, Kobori H, Moriguchi K, Nakashima H, Matumoto Y, Takahara S, Ebina T, Katakura R. Selective tumoricidal effect of soluble proteoglucan extracted from the basidiomycete, Agaricus blazei Murill, mediated via natural killer cell activation and apoptosis. Cancer Immunol Immunother 46:147-159, 1998.
8. Takaku T, Kimura Y, Okuda H. Isolation of an antitumor compound from Agaricus blazei Murill and its mechanism of action. J Nutr 131:1409-1413, 2001.
9. Delmanto RD, Alves de Lima PL, Sugui MM, da Eira AF, Salvadori DM, Speit G, Ribeiro LR. Antimutagenic effect of Agaricus blazei Murrill mushroom on the genotoxicity induced by cyclophosphamide. Mutat Res 496:15-21, 2001.
10. Barbisan LF, Miyamoto M, Scolastici C, Salvadori DMF, Ribeiro LR, Eira AF, de Camargo JLV. Influence of aqueous extract of Agaricus blazei on rat liver toxicity induced by different doses of diethylnitrosamine. J Ethnopharmacol 83:25-32, 2002.
11. Barbisan LF, Spinardi-Barbisan AL, Moreira EL, Salvadori DM, Ribeiro LR, da Eira AF, de Camargo JL. Agaricus blazei (Himematsutake) does not alter the development of rat diethylnitrosamine-initiated hepatic preneoplastic foci. Cancer Sci 94:188-192, 2003.
12. Pinheiro F, Faria RR, de Camargo JLV, Spinardi-Barbisan ALT, da Eira AF, Barbisan LF. Chemoprevention of preneoplastic liver foci by dietary mushroom Agaricus blazei Murill in the rat. Food Chem Toxicol 41:1543-1550, 2003.
13. Alves de Lima PL, Delmanto RD, Sugui MM, da Eira AF, Salvadori DM, Speit G, Ribeiro LR. Letinula edodes (Berk.) Pegler (Shiitake) modulates genotoxic and mutagenic effects induced by alkylating agents in vivo. Mutat Res 496:23-32, 2001.
14. Sugui MM, Alves de Lima PL, Delmanto RD, da Eira AF, Salvadori DMF, Ribeiro LR. Antimutagenic effect of Lentinula edodes (BERK.) Pegler mushroom and possible variation among lineages. Food Chem Toxicol 41:555-560, 2003.
15. Zhang Y, Mills GL, Nair MG. Cyclooxygenase inhibitory and antioxidant compounds from the mycelia of the edible mushroom Grifola frondosa. J Agric Food Chem 50:7581-7585, 2002.
16. Prescott SM, Fitzpatrick FA. Cyclooxygenase-2 and carcinogenesis. Biochim Biophys Acta 1470:M69-M78, 2000.
17. Itoh H, Ito H, Amano H, Noda H. Inhibitory action of a (1→6)-beta-D-glucan-protein complex (F 111-2-b) isolated from Agaricus blazei Murill ("himematsutake") on Meth A fibrosarcoma-bearing mice and its antitumor mechanism. Jpn J Pharmacol 66:265-271, 1994.
18. Mizuno M, Morimoto M, Minato K, Tsuchida H. Polysaccharides from Agaricus blazei stimulate lymphocyte T-cell subsets in mice. Biosci Biotechnol Biochem 62:434-437, 1998.
19. Mizuno M, Minato K, Ito H, Kawade M, Terai H, Tsuchida H. Antitumor polysaccharide from the mycelium of liquid-cultured Agaricus blazei mill. Biochem Mol Biol Int 47:707-714, 1999.
20. Sorimachi K, Akimoto K, Ikehara Y, Inafuku K, Okubo A, Yamazaki S. Secretion of TNF-α IL-8 and nitric oxide by macrophages activated with Agaricus blazei Murill fractions in vitro. Cell Struct Funct 26:103-108, 2001.
21. Ng ML, Yap AT. Inhibition of human colon carcinoma development by lentinan from shiitake mushrooms (Lentinus edodes). J Altern Complement Med 8:581-589, 2002.
22. Ukawa Y, Ito H, Hisamatsu M. Antitumor effects of (1→3)-β -D-glucan and (1→6)-β-D-glucan purified from newly cultivated mushroom. Hatakeshimeji (Lyophyllum decastes Sing.). J Biosci Bioeng 90:98-104, 2000.
23. Tsang KW, Lam CL, Yan C, Mak JC, Ooi GC, Ho JC, Lam B, Man R, Sham JS, Lam WK. Coriolus versicolor polysaccharide peptide slows progression of advanced non-small cell lung cancer. Respir Med 97:618-624, 2003.
24. Gao Y, Zhou S, Chen G, Dai X, Ye J. A phase I/II study of a Ganoderma lucidum (Curt.: Fr.) P. Karst. extract (Ganopoly) in patients with advanced cancer. Int J Med Mushrooms 4:207-214, 2002.
25. Kodama N, Komuta K, Sakai N, Nanba H. Effects of D-fraction, a polysaccharide from Grifola frondosa on tumor growth involve activation of NK cells. Biol Pharm Bull 25:1647-1650, 2002.
26. Kodama N, Komuta K, Nanba H. Can maitake MD-fraction aid cancer patients? Altern Med Rev 7:236-239, 2002.
27. deVere White RW, Hackman RM, Soares SE, Beckett LA, Sun B. Effects of a mushroom mycelium extract on the treatment of prostate cancer. Urology 60:640-644, 2002.
28. Yap AT, Ng ML. An improved method for the isolation of lentinan from shiitake mushroom (Lentinus edodes). Int J Med Mushrooms 3:9-19, 2001.
29. Jin M, Jeon H, Jung HJ, Kim B, Shin SS, Choi JJ, Lee JK, Kang CY, Kim S. Enhancement of repopulation and hematopoiesis of bone marrow cells in irradiated mice by oral administration of PG101, a water-soluble extract from Lentinus lepideus. Exp Biol Med (Maywood) 228:759-766, 2003.
30. Ohno N, Harada T, Masuzawa S, Miura NN, Adachi Y, Nakajima M, Yadomae T. Antitumor activity and hematopoietic response of a β-glucan extracted from an edible and medicinal mushroom Sparassis crispa Wulf.: Fr. (Aphyllophoromycedtideae). Int J Med Mushrooms 4:13-26, 2002.
31. Harada T, Miura N, Adachi Y, Nakijima M, Yadomae T, Ohn N. Effect of SCG, 1,3-β-D-glucan from Sparassis crispa on the hematopoietic response in cyclophosphamide induced leukopenic mice. Biol Pharm Bull 25:931-939, 2002.
32. Sano M, Yoshino K, Matsuzawa T, Ikekawa T. Inhibitory effects of edible higher Basidiomycetes mushroom extracts on mouse type IV allergy. Int J Med Mushrooms 4:37-41, 2002.
33. Kim GY, Kim SH, Hwang SY, Kim HY, Park YM, Park SK, Lee MK, Lee SH, Lee TH, Lee JD. Oral administration of proteoglycan isolated from Phellinus linteus in the prevention and treatment of collagen-induced arthritis in mice. Biol Pharm Bull 26:823-831, 2003.
34. Shigesue K, Kodama N, Nanba H. Effects of maitake (Grifola frondosa) polysaccharide on collagen-induced arthritis in mice. Jpn J Pharmacol 84:293-300, 2000.
35. Kodama N, Yamada M, Nanba H. Addition of Maitake D-fraction reduces the effective dosage of vancomycin for the treatment of Listeria-infected mice. Jpn J Pharmacol 87:327-332, 2001.
36. Kim GY, Roh SI, Park SK, Ahn SC, Oh YH, Lee JD, Park YM. Alleviation of experimental septic shock in mice by acidic polysaccharide isolated from the medicinal mushroom Phellinus linteus. Biol Pharm Bull 26:1418-1423, 2003.
37. Liu F, Ooi VEC, Fung MC. Analysis of immunomodulating cytokine mRNAs in the mouse induced by mushroom polysaccharides. Life Sci 64:1005-1011, 1999.
38. Suzuki Y, Adachi Y, Ohno N, Yadomae T. Th1/Th2-balancing immunomodulating activity of gel-forming (1→3)-β-glucans from fungi. Biol Pharm Bull 24:811-819, 2001.
39. Jeannin P, Delneste Y, Lecoanet-Henchoz S, Gauchat JF, Life P, Holmes D, Bonnefoy JY. Thiols decrease human interleukin (IL) 4 production and IL-4-induced immunoglobulin synthesis. J Exp Med 182:1785-1792, 1995.
40. Peterson JD, Herzenberg LA, Vasquez K, Waltenbaugh C. Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. Proc Natl Acad Sci U S A 95:3071-3076, 1998.
41. h2 balance is dependent on the intracellular thiol redox status of macrophages due to the distinctive cytokine production. Int Immunol 14:201-212, 2002.
42. Murata Y, Ohteki T, Koyasu S, Hamuro J. IFN-g and pro-inflammatory cytokine production by antigen-presenting cells is dictated by intracellular thiol redox status regulated by oxygen tension. Eur J Immunol 32:2866-2873, 2002.
43. Adachi Y, Suzuki Y, Jinushi T, Yadomae T, Ohno N. Th1-oriented immunomodulating activity of gel-forming fungal (1-.3)-beta-glucans. Int J Med Mushrooms 4:95-109, 2002.
44. Suzuki T, Tsuzuki A, Ohno N, Ohshima Y, Adachi Y, Yadomae T. Synergistic action of β-glucan and platelets on interleukin-8 production by human peripheral blood leukocytes. Biol Pharm Bull 25:140-144, 2002.
45. Murata Y, Shimamura T, Tagami T, Takatsuki F, Hamuro J. The skewing to Th1 induced by lentinan is directed through the distinctive cytokine production by macrophages with elevated intracellular glutathione content. Int Immunopharmacol 2:673-689, 2002.
46. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 164:6166-6173, 2000.
47. Inoue A, Kodama N, Nanba H. Effect of maitake (Grifola frondosa) D-fraction on the control of the T lymph node Th-1/Th-2 proportion. Biol Pharm Bull 25:536-540, 2002.
48. Kodama N, Harada N, Nanba H. A polysaccharide, extract from Grifola frondosa, induces Th-1 dominant responses in carcinoma-bearing BALB/c mice. Jpn J Pharmacol 90:357-360, 2002.
49. Harada N, Kodama N, Nanba H. Relationship between dendritic cells and the D-fraction-induced Th-1 dominant response in BALB/c tumor-bearing mice. Cancer Lett 192:181-187, 2003.
50. Maldonado-Lopez R, De Smedt T, Michel P, Godfroid J, Pajak B, Heirman C, Thielemans K, Leo O, Urbain J, Moser M. CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med 189:587-592, 1999.
51. Pulendran B, Smith JL, Caspary G, Brasel K, Pettit D, Maraskovsky E, Maliszewski CR. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci U S A 96:1036-1041, 1999.
52. Kim GY, Oh YH, Park YM. Acidic polysaccharide isolated from Phellinus linteus induces nitric oxide-mediated tumoricidal activity of macrophages through protein tyrosine kinase and protein kinase C. Biochem Biophys Res Commun 309:399-407, 2003.
53. Falch BH, Espevik T, Ryan L, Stokke BT. The cytokine stimulating activity of (1→3)-β-D-glucans is dependent on the triple helix conformation. Carbohydr Res 329:587-596, 2000.
54. Thornton BP, Vetvicka V, Pitman M, Goldman RC, Ross GD. Analysis of the sugar specificity and molecular location of the β-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J Immunol 156:1235-1246, 1996.
55. Xia Y, Vetvicka V, Yan J, Hanikyrova M, Mayadas T, Ross GD. The β-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells. J Immunol 162:2281-2290, 1999.
56. Vetvicka V, Thornton BP, Wieman TJ, Ross GD. Targeting of natural killer cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and β-glucan-primed CR3 (CD11b/CD18). J Immunol 159:599-605, 1997.
57. Yan J, Vetvicka V, Xia Y, Coxon A, Carroll MC, Mayadas TN, Ross GD. β-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18). J Immunol 163:3045-3052, 1999.
58. Miura T, Miura NN, Olmo N, Adachi Y, Shimada S, Yadomae T. Failure in antitumor activity by overdose of an immunomodulating β-glucan preparation, sonitilan. Biol Pharm Bull 23:249-253, 2000.
59. Mueller A, Raptis J, Rice PJ, Kalbfleisch JH, Stout RD, Ensley HE, Browder W, Williams DL. The influence of glucan polymer structure and solution conformation on binding to (1→3)-β-D-glucan receptors in a human monocyte-like cell line. Glycobiology 10:339-346, 2000.
60. Michalek M, Melican D, Brunke-Reese D, Langevin M, Lemerise K, Galbraith W, Patchen M, Mackin W. Activation of rat macrophages by Betafectin® PGG-glucan requires cross-linking of membrane receptors distinct from complement receptor three (CR3). J Leukoc Biol 64:337-344, 1998.
61. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. Collaborative induction of inflammatory responses by dectin-1 and toll-like receptor 2. J Exp Med 197:1107-1117, 2003.
62. Lowe E, Rice P, Ha T, Li C, Kelley J, Ensley H, Lopez-Perez J, Kalbfleisch J, Lowman D, Margl P, Browder W, Williams D. A (1→3)-β -D-linked heptasaccharide is the unit ligand for glucan pattern recognition receptors on human monocytes. Microbes Infect 3:789-797, 2001.
63. Wakshull E, Brunke-Reesc D, Lindermuth J, Fisette L, Nathans RS, Crowley JJ, Tufts JC, Zimmerman J, Mackin W, Adams DS. PGG-glucan, a soluble β-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates an NF-κB-like factor in human PMN: evidence for a glycosphingolipid b-(1,3)-glucan receptor. Immunopharmacology 41:89-107, 1999.
64. Brown GD, Taylor PR, Reid DM, Willment JA, Williams DL, Martinez-Pomares L, Wong SY, Gordon S. Dectin-1 is a major β-glucan receptor on macrophages. J Exp Med 196:407-412, 2002.
65. Brown GD, Gordon S. Immune recognition. A new receptor for β-glucans. Nature 413:36-37, 2001.
66. Brown GD, Herre J, Williams DL, Willment JA, Marshall AS, Gordon S. Dectin-1 mediates the biological effects of β-glucans. J Exp Med 197:1119-1124, 2003.
67. Pearson A, Lux A, Krieger M. Expression cloning of dSR-C1, a class C macrophage-specific scavenger receptor from Drosophila melanogaster. Proc Natl Acad Sci U S A 92:4056-4060, 1995.
68. Zimmerman JW, Lindermuth J, Fish PA, Palace GP, Stevenson TT, DeMong DE. A novel carbohydrate-glycosphingolipid interaction between a β-(1-3) -glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytes. J Biol Chem 273:22014-22020, 1998.
69. Czop JK, Austen KF. A β-glucan inhibitable receptor on human monocytes: its identity with the phagocytic receptor for particulate activators of the alternative complement pathway. J Immunol 134:2588-2593, 1985.
70. Szabó T, Kadish JL, Czop JK. Biochemical properties of the ligand-binding 20-kDa subunit of the β-glucan receptors on human mononuclear phagocytes. J Biol Chem 270:2145-2151, 1995.
71. Medzhitov R, Janeway C Jr. Innate immune recognition: mechanisms and pathways. Immunol Rev 173:89-97, 2000.
72. Underhill DM. Toll-like receptors: networking for success. Eur J Immunol 33:1767-1775, 2003.
73. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, Schroeder L, Aderem A. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci U S A 97:13766-13771, 2000.
74. Taylor PR, Brown GD, Reid DM, Willment JA, Martinez-Pomares L, Gordon S, Wong SY. The β-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. J Immunol 169:3876-3882, 2002.
75. Ariizumi K, Shen GL, Shikano S, Xu S, Ritter R 3rd, Kumamoto T, Edelbaum D, Morita A, Bergstresser PR, Takashima A. Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning. J Biol Chem 275:20157-20167, 2000.
76. Oka M, Hazama S, Suzuki M, Wang F, Wadamori K, Iizuka N, Takeda S, Akitomi Y, Ohba Y, Kajiwara K, Suga T, Suzuki T. In vitro and in vivo analysis of human leukocyte binding by the antitumor polysaccharide, lentinan. Int J Immunopharmacol 18:211-216, 1996.
77. Willment JA, Gordon S, Brown GD. Characterization of the human β-glucan receptor and its alternatively spliced isoforms. J Biol Chem 276:43818-43823, 2001.
78. Cario E, Rosenberg IM, Brandwein SL, Beck PL, Reinecker HC, Podolsky DK. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing toll-like receptors. J Immunol 164:966-972, 2000.
79. Cario E, Brown D, McKee M, Lynch-Devaney K, Gerken G, Podolsky DK. Commensal-associated molecular patterns induce selective toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium. Am J Pathol 160:165-173, 2002.
80. Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, Bonasio R, Granucci F, Kraehenbuhl JP, Ricciardi-Castagnoli P. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2:361-367, 2001.
81. Battle J, Ha T, Li C, Della Beffa V, Rice P, Kalbfleisch J, Browder W, Williams D. Ligand binding to the (1→3)-β-D-glucan receptor stimulates NFkB activation, but not apoptosis in U937 cells. Biochem Biophys Res Commun 249:499-504, 1998.
82. Hirata N, Tsuzuki A, Ohno N, Saita M, Adachi Y, Yadomae T. Cytokine synthesis of human monocytes stimulated by triple or single helical conformer of an antitumour (1→3)-P-D-glucan preparation, sonifilan. Zentralbl Bakteriol 288:403-413, 1998.
83. Tsuzuki A, Tateishi T, Ohno N, Adachi Y, Yadomae T. Increase of hematopoietic responses by triple or single helical conformer of an antitumor (1→3)-β-D-glucan preparation, Sonifilan, in cyclophosphamide-induced leukopenic mice. Biosci Biotechnol Biochem 63:104-110, 1999.
84. Kataoka K, Muta T, Yamazaki S, Takeshige K. Activation of macrophages by linear (1→3)-β-D-glucans. Implications for the recognition of fungi by innate immunity. J Biol Chem 277:36825-36831, 2002.
85. Minato K, Mizuno M, Terai H, Tsuchida H. Autolysis of lentinan, an antitumor polysaccharide, during storage of Lentinus edodes, shiitake mushroom. J Agric Food Chem 47:1530-1532, 1999.
86. Ohno N, Furukawa M, Miura NN, Adachi Y, Motoi M, Yadomae T. Antitumor β-glucan from the cultured fruit body of Agaricus blazei. Biol Pharm Bull 24:820-828, 2001.
87. Ohno N, Miura NN, Nakajima M, Yadomae T. Antitumor 1,3-β-glucan from cultured fruit body of Sparassis crispa. Biol Pharm Bull 23:866-872, 2000.
88. Ajith TA, Janardhanan KK. Cytotoxic and antitumor activities of a polypore macrofungus, Phellinus rimosus (Berk) Pilat. J Ethnopharmacol 84:157-162, 2003.
89. Jose N, Ajith TA, Jananrdhanan KK. Antioxidant, anti-inflammatory, and antitumor activities of culinary-medicinal mushroom Pleurotus pulmonarius (Fr.) Quél. (Agaricomycetideae). Int J Med Mushrooms 4:329-335, 2002.
90. Bezivin C, Deleros J-G, Fortin H, Amoros M, Boustie J. Toxicity and antitumor activity of a crude extract from Lepista inversa (Scop.: Fr.) Pal. (Agaricomycerideae): A preliminary study. Int J Med Mushrooms 5:25-30, 2003.